Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-311826
Filing Date
2022-12-23
Accepted
2022-12-23 16:55:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d404958d424b5.htm 424B5 365740
2 EX-FILING FEES d404958dexfilingfees.htm EX-FILING FEES 13964
3 GRAPHIC g404958g03d10.jpg GRAPHIC 51822
4 GRAPHIC g404958g73v66.jpg GRAPHIC 36163
  Complete submission text file 0001193125-22-311826.txt   498099
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255792 | Film No.: 221485935
SIC: 2836 Biological Products, (No Diagnostic Substances)